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Abstract
Background: Human tonsils are a rich source of B lymphocytes exhibiting a variety of phenotypes
and activation states. Existing methods of purification are time consuming or costly. The aim of the
present study was to optimize conditions to isolate large numbers of highly purified primary B
lymphocytes from tonsils in a short and cost-effective single step, using a commercially available
reagent designed for purifying cells from whole blood (RosetteSep). This technique relies on the
presence of the large excess of red blood cells in whole blood for the formation of
immunorosettes, whereas single cell suspensions from tonsils contain relatively few red blood cells.
Results: B cell enrichment from tonsils was achieved using RosetteSep with no modification to the
whole blood procedure; however, the degree of purity depended on the extent of red blood cell
contamination of the starting tonsil cell suspension. Addition of a 50-fold excess of allogeneic
human red blood cells, but not sheep red blood cells, reproducibly resulted in high levels of purity.
Depletion of mononuclear cells from the donor red blood cells eliminated potential contamination
with allogeneic B cells.
Conclusion: RosetteSep reagent can be used in combination with allogeneic human red blood
cells to reproducibly isolate tonsil B lymphocytes to high levels of purity with no change in
phenotype or loss of cells. This method provides considerable time and cost savings compared to
other methods.
Background
Human tonsils are a rich source of B lymphocytes exhibit-
ing a variety of phenotypes and activation states. A well-
established method for enriching B lymphocytes from
tonsils involves the addition of 2-aminoethylisothiouro-
nium bromide (AET) modified sheep red blood cells
(RBCs) to deplete T lymphocytes by rosetting [1-3]. This is
a relatively inefficient method, requiring advance acquisi-
tion and treatment of sheep RBCs, and several time-con-
suming steps on the day of cell separation. Additionally,
while this method results in significant enrichment of B
lymphocytes, there is often up to 8% contaminating T
cells [2]. Magnetic cell separation techniques can yield
highly purified populations of either negatively or posi-
tively selected B lymphocytes, but the high cost of reagents
can be prohibitive when isolating very large numbers of
cells.
In this study we describe a rapid and cost-effective
approach for purifying large numbers of B lymphocytes
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from tonsils using a commercially available reagent,
RosetteSep, which was designed for purifying cells from
whole blood. The RosetteSep Human B cell Enrichment
Cocktail consists of tetrameric antibody complexes with
specificities for CD2, CD3, CD16, CD36, CD56, CD66b,
and glycophorin-A. Addition of this antibody cocktail to
whole blood results in crosslinking of unwanted cells with
multiple RBCs to form immunorosettes that pellet when
centrifuged over a lymphocyte separation density
medium, while B lymphocytes collect at the interphase.
This technique relies on the presence of the large excess of
RBCs in whole blood for the formation of immunoro-
settes. Single cell suspensions from tonsils contain rela-
tively few RBCs. Here, we show that by addition of human
but not sheep RBCs to tonsil cell suspensions, RosetteSep
can be used to rapidly obtain large numbers of highly
purified B cells.
Results
Removal of lymphocytes from donor RBCs
We proposed to add allogeneic human RBCs to unfrac-
tionated tonsil cell suspensions in order to optimize the
use of RosetteSep for B cell isolation from tonsils. First, it
was necessary to consider potential contamination of the
final product with B lymphocytes from the whole blood
used to obtain RBCs. In healthy individuals white blood
cells make up 0.08–0.22% of cells in the blood; B lym-
phocytes comprise 5–25% of this fraction, depending on
the age of the donor [4,5]. Given the large excess of RBCs
to be added to unfractionated tonsil cells, the use of
human blood as a source of RBCs could result in signifi-
cant contamination with non-tonsil B lymphocytes. In
order to avoid contaminating tonsil B lymphocytes with
allogeneic blood B lymphocytes during the purification,
we first depleted mononuclear cells from the RBCs by cen-
trifugation over lymphocyte separation medium. As
expected, the mononuclear cells removed from whole
blood were largely CD3 or CD19 positive as determined
by flow cytometery (data not shown). A more sensitive
measure, reverse-transcription PCR, was used to detect T
and B cells in the RBC preparation before and after deple-
tion (Figure 1). PCR products for both CD3 and CD20
were detected in samples of whole blood and the mono-
nuclear cell fraction. The purified RBC preparation
showed no CD3 or CD20 PCR product, indicating that it
was free of lymphocyte contamination.
Isolation of tonsil B lymphocytes using RosetteSep
Tonsil lymphocyte suspensions include 40–80% B lym-
phocytes, with T lymphocytes comprising the bulk of the
remaining cells. Figure 2 shows a typical purification of B
lymphocytes from tonsils using RosetteSep. In the unpu-
rified tonsil cell suspension shown, there were 58.3% B
cells and 23.4% T cells (Figure 2A). RosetteSep purifica-
tion of B lymphocytes without the addition of RBCs
resulted in approximately 91.6% purity with 6% T cell
contamination (Figure 2A). Addition of human RBCs
improved the purification to 98.9%, reducing the amount
of T cell contamination to 1% (Figure 2A).
Sheep RBCs have been used for tonsil B lymphocyte isola-
tion by RosetteSep [6]. However, we found that the addi-
tion of sheep RBCs provided no improvement in B
lymphocyte purity over that obtained without added
RBCs (Figure 2A). Additionally, we found that tonsil B
cells purified with either sheep RBCs or no added RBCs
gave a reproducible PCR product for CD3 after 35 cycles,
whereas there was no evidence of CD3 in tonsil B lym-
phocytes purified with human RBCs (Figure 2B).
To assess cell loss during this procedure, we determined
the percent of CD19+ lymphocytes in unfractionated ton-
sil cell suspensions using flow cytometry. After purifica-
tion, the total number of recovered B cells was determined
and expressed as a percentage of the estimated input
number. It was found that this method of B lymphocyte
purification reproducibly yielded greater than 99% recov-
ery.
To further assess the utility of this method, the B lym-
phocyte phenotypes were examined before and after puri-
fication, using flow cytometry to detect CD19, CD38 and
IgD. Unpurified tonsil lymphocytes were gated on CD19
expression before examining the CD38/IgD profile (Fig-
ure 3, upper panels). RosetteSep with the addition of
human RBCs resulted in a 99% pure population of B-lym-
phocytes with a CD38/IgD profile similar to that of the
corresponding tonsil cells, suggesting that all B lym-
phocyte populations are preserved during purification
(Figure 3, lower panels).
Depletion of lymphocytes from donor blood Figure 1
Depletion of lymphocytes from donor blood. To test 
for lymphocyte contamination of donor RBCs, cDNA was 
generated from whole blood (WB), purified RBCs and mono-
nuclear cells (MC). CD20, CD3-γ and beta actin were ampli-
fied by PCR (n = 2).
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Discussion
We describe in this report the application of RosetteSep
for isolation of tonsil B lymphocytes to very high purity.
Significant enrichment can be obtained using RosetteSep
without the addition of RBCs (Figure 2A), the degree of
purity depending on the extent of RBC contamination of
the starting tonsil cell suspension (data not shown). How-
ever, the addition of excess human RBCs was found to be
essential for reproducibly obtaining B cell purity above
98%; sheep RBCs could not be substituted likely owing to
Comparison of tonsil B lymphocytes isolated using RosetteSep with added human or sheep RBCs Figure 2
Comparison of tonsil B lymphocytes isolated using RosetteSep with added human or sheep RBCs. A. Unpurified 
tonsil cells, and B lymphocytes isolated using RosetteSep without added RBCs (n = 5), or with sheep RBCs (n = 2), or with 
human RBCs (n = 9), were analyzed by flow cytometry using anti-CD19 and anti-CD3, as indicated. Percentages of CD19-pos-
itive and CD3-positive cells in a representative experiment are shown. B. Reverse transcription PCR was used to further 
examine the purity of the tonsil B lymphocyte preparations. A PCR product for CD3-γ was amplified from cells purified with 
either no added RBCs or sheep RBCs (upper panel), but no PCR product was detected in cells purified using added human 
RBCs (n = 2). CD20 and beta actin were amplified to show that there were equal amounts of cDNA used for amplification.
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species specificity of the anti-glycophorin-A antibody in
the RosetteSep cocktail.
Potential contamination with blood B cells from the RBC
donor was eliminated by depletion of mononuclear cells
from the RBC preparation; RBCs could then be stored for
several weeks without significant hemolysis. The
RosetteSep method with added human RBCs represents a
significant improvement over current methods (AET-
treated sheep RBCs and selection with immunomagnetic
beads). Compared to the AET-treated sheep RBCs
method, there are significant time savings in the purifica-
tion procedure as well as in the RBC preparation; the sta-
bility of stored human RBCs compared to AET-treated
sheep RBCs is a further advantage. Purification using
immunomagnetic beads is equally efficient, however,
RosetteSep is less than 10% of the cost for purification of
an equal number of B lymphocytes. Thus we recommend
the use of this modified RosetteSep technique for obtain-
ing any number of highly purified tonsil B lymphocytes.
Conclusion
RosetteSep can be used in combination with allogeneic
human RBCs to reproducibly isolate tonsil B lymphocytes
to high levels of purity with no change in phenotype or
loss of cells. This method provides considerable time and
cost savings compared to other methods.
Methods
Antibodies and reagents
Phycoerythrin (PE) conjugated anti-IgD, anti-CD3 and
isotype control, IgG1, were from Becton Dickinson (Mis-
sissauga, ON). Tri-color (TC) conjugated anti-CD19 was
from Caltag (Burlingame, AL). FITC conjugated anti-
CD38 was from Abcam (Cambridge, UK). RosetteSep
human B lymphocyte enrichment cocktail was purchased
from StemCell Technologies Inc. (Vancouver, BC). Sheep
RBCs were purchased from Cedarlane Laboratories Ltd
(Hornby, ON).
Tonsils
Tonsils were obtained from the Alberta Children's Hospi-
tal with ethical approval. Cell suspensions were prepared
by cutting the tissue into fine pieces using scissors or razor
blades in RPMI 1640 (Gibco Laboratories, Grand Island,
NY) supplemented with 10% fetal bovine serum (FBS)
(Gibco). The tonsil tissue fragments were then forced
through a nylon screen of 70 μm mesh size to disrupt the
pieces into single cells. Cells were then washed twice with
RPMI/FBS and counted.
Preparation of human red blood cells
Human blood was collected from healthy donors into
heparin vacutainers. Mononuclear cells were removed by
diluting the whole blood with an equal volume of RPMI/
FBS, layering over lymphocyte separation medium (MP
Biomedicals LLC, Solon, OH), and then centrifugation at
1160 × g for 20 minutes with no brake. Cells at the inter-
phase were aspirated and discarded, while the loosely pel-
leted RBCs were washed and returned to their original
volume using Alsever's solution. Prepared RBCs were
counted and used for up to one month. All steps were per-
formed at room temperature.
Purification of tonsil B lymphocytes
To purify B lymphocytes, 2 × 108 tonsil cells were mixed
with a 50-fold excess (1010) of human or sheep RBCs. The
cells were centrifuged at 350 × g for 5 minutes and then
resuspended in 4 mL of RPMI/FBS. 200 μl of RosetteSep
was then added; the sample was gently mixed by rocking
and incubated for 20 minutes. The sample was then
diluted with an equal volume of phosphate buffered
saline (PBS) containing 2% FBS and 1 mM EDTA. Lym-
phocyte separation medium was carefully layered under
the preparation and centrifuged for 20 minutes at 1160 ×
g with no brake. Cells at the interface were collected,
washed and saved for analysis. All steps were performed at
room temperature.
Comparison of tonsil B lymphocyte phenotypes before and  after purification Figure 3
Comparison of tonsil B lymphocyte phenotypes 
before and after purification. Unpurified tonsil cells 
(upper panels) and purified B cells (lower panels) were 
stained with anti-CD19-TC, anti-IgD-PE and anti-CD38-
FITC, and analyzed by flow cytometry. Unpurified tonsil lym-
phocytes were gated for CD19 expression before analyzing 
the IgD/CD38 profile (n = 5).
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Reverse transcription PCR
Up to 107 cells were used to prepare total RNA using the
RNeasy mini kit (Qiagen, Valencia, CA). 5 μg of total RNA
was reverse transcribed using Superscript III (Invitrogen,
Carlsbad, CA) with oligo dT primers. Polymerase chain
reaction (PCR) was performed in 25 μl volumes with TAQ
PCR master mix (Qiagen, Valencia, CA) using 35 cycles of
1 min at 95°C, 1 min at 58°C, and 50 sec at 72°C. Prim-
ers for CD20: forward 5' GCA GCA ACG GAG AAA AAC
TC 3' and reverse 5' GAA GAA GCG TGA CAA CAC AAG
3'. Primers for CD3: forward 5' CTG GGA AGT AAT GCC
AAG GA 3' and reverse 5' TAG ACC CCA ACA GCA AGG
AC 3'. Primers for Beta actin: forward 5' CAC TCT TCC
AGC CTT CCT TCC 3' and reverse 5' GTG TTG GCG TAC
AGG TCT TTG 3'. PCR products were resolved on 1% aga-
rose Tris-Borate-EDTA (TBE) gels with ethidium bromide
and photographed to observe relative signals of each
amplified transcript.
Flow cytometry
Cells were incubated with directly conjugated antibodies
for 15 min at room temperature, washed and acquired on
a flow cytometer (FACScan, Becton Dickinson). The data
were analyzed using the FlowJo program (Tree Star Inc,
San Carlo, CA).
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